Skip to content
Briefings are running a touch slower this week while we rebuild the foundations.See roadmap
Pandemics and Biosecurity
17MAY

Uganda runs 2022 Sudan Ebola playbook

3 min read
11:07UTC

Diana Atwine confirmed Uganda's index case on Thursday 14 May: a 59-year-old Congolese man admitted to Kibuli Muslim Hospital on Monday 11 May who died three days later; a mobile lab has been deployed to Bwera Hospital on the DRC border.

ScienceDeveloping
Key takeaway

Uganda is running its 2022 Sudan ebolavirus playbook on a different species, again without a licensed vaccine.

Diana Atwine, Permanent Secretary at the Uganda Ministry of Health, confirmed the Kampala index case as imported on Thursday 14 May 1. A 59-year-old Congolese man was admitted to Kibuli Muslim Hospital on Monday 11 May and died on Thursday 14 May. "This is an imported case from DRC. The country has not yet confirmed a local case," Atwine said. A second Kampala case was subsequently confirmed in the Sunday WHO declaration. At least 25 contacts are under monitoring across Kampala and the Kasese border area, per the Africa CDC 16 May coordination call 2.

A mobile laboratory has been deployed to Bwera Hospital in Kasese district on the DRC border, per WHO AFRO 3. The Kasese deployment shortens the confirmation window for suspected cases arriving across the Ituri frontier from the several days needed to route samples to Kampala to the same-day turnaround INRB has been running inside DRC. Uganda has activated border screening at western entry points and along transit routes between Kasese and Kampala. The cross-border surveillance corridor with South Sudan is being expanded in parallel; South Sudan shares a 600-kilometre border with Uganda's northwest and was named in Africa CDC's 15 May grouping of at-risk states alongside DRC and Uganda.

Uganda's operational precedent is its own 2022 Sudan ebolavirus outbreak, in which 142 confirmed cases were contained in 113 days through contact tracing alone, without any licensed vaccine. Sudan ebolavirus has no Ervebo cross-protection in trial data, just as Bundibugyo has none. That 2022 containment, accomplished without a vaccine ring, is the closest operational template for what Kampala is now attempting. Atwine ran the senior coordination layer in 2022 and is running it again. The differences from 2022 are upstream: the ARILAC network gives Africa CDC a direct line into Uganda's border surveillance at greater institutional depth than three years ago, while the federal-CDC layer that supplied 2018 Equateur with embedded staff is no longer available in the same form.

Deep Analysis

In plain English

Uganda has dealt with Ebola outbreaks before, more than any other country. In 2022, Uganda stopped a 142-case Sudan Ebola outbreak without any vaccine, just by finding every person who had been near a sick person and checking them daily for three weeks. The 2022 response ran for 113 days without a single imported secondary case outside the initial district. But that 2022 outbreak started in a rural district. This one started in Kampala, Uganda's capital of four million people. A sick man from DRC travelled to Kampala, went to a hospital, and died. Now the health authorities need to find every person who may have had contact with him: at the hospital, on transport, potentially at his home. That is much harder in a big city than in a village.

What could happen next?
  • Risk

    The Kampala index case's contact footprint likely includes at least one medical facility, one or more transport routes from the DRC border, and community contacts in Kampala: potentially hundreds of contacts compared to the manageable clusters in Uganda's 2022 rural response.

  • Consequence

    A second Kampala case already confirmed in the WHO PHEIC technical assessment means community transmission has not yet been ruled out, keeping the contact footprint open-ended.

First Reported In

Update #3 · WHO calls Ebola PHEIC, no treatment exists

Africa CDC· 17 May 2026
Read original
Different Perspectives
CIDRAP / Michael Osterholm
CIDRAP / Michael Osterholm
CIDRAP's coverage framed the Bundibugyo outbreak against simultaneous H5N1 and Andes hantavirus pressures on the same federal response budget and noted that MCM development for neglected non-Zaire Ebola species is the unresolved gap in the post-2014 preparedness rebuild. The first Bundibugyo PHEIC arrives with that gap confirmed open.
Resolve to Save Lives / Tom Frieden
Resolve to Save Lives / Tom Frieden
Frieden's 7-1-7 metric (outbreak detected within 7 days, reported within 1, responded to within 7) was violated on all three counts in Ituri: detection lagged by four-plus weeks, the WHO signal came five or more weeks after community deaths, and the response opened at 246 suspected cases rather than at index.
Uganda Ministry of Health / Diana Atwine
Uganda Ministry of Health / Diana Atwine
Permanent Secretary Atwine confirmed the Kampala index case as imported on 14 May and activated protocols rehearsed in Uganda's 2022 Sudan ebolavirus response, which contained 142 confirmed cases in 113 days without a licensed vaccine. A mobile laboratory at Bwera Hospital on the DRC border shortens cross-border confirmation to same-day.
DRC Ministry of Health
DRC Ministry of Health
No formal public statement had been issued by the DRC Ministry of Health as of the 17 May WHO PHEIC declaration. WHO AFRO confirmed Kinshasa has activated national coordination mechanisms; the ministry's own communications channel has not produced named attribution or revised case counts.
US federal public-health bench / Jay Bhattacharya and Brian Christine
US federal public-health bench / Jay Bhattacharya and Brian Christine
Jay Bhattacharya holds both the NIH Director and acting CDC Director roles simultaneously; Brian Christine, an Alabama urologist confirmed in October 2025, is the HHS Assistant Secretary for Health. The combination is the thinnest senior US public-health roster since 2014, and neither position has a confirmed CDC director, confirmed FDA commissioner, or confirmed ASPR head alongside it.
Imperial College London / Anne Cori and Neil Ferguson
Imperial College London / Anne Cori and Neil Ferguson
Cori and Ferguson placed the case-fatality rate at 30 to 40 per cent and assessed the outbreak had likely gone undetected for weeks or months before the 5 May WHO signal. The four-week community-to-signal gap converts the INRB confirmation turnaround from a success story into evidence of an upstream surveillance failure.